Ikarian Capital, LLC Maxcyte, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.59 - $6.81 $495,269 - $939,493	-137,958 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.26 - $10.84 $41,859 - $86,264	7,958 Added 6.12%	137,958 $964,000
Q4 2021 Feb 14, 2022	SELL	$8.87 - $12.94 $177,399 - $258,800	-20,000 Reduced 13.33%	130,000 $1.33 Million
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $1.83 Million - $2.58 Million	150,000 New	150,000 $1.83 Million

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $451M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.